Skip to main content

Table 4 Associations of CYP11B1 polymorphisms and CHD risk stratified by diabetes and hypertension

From: Genetic variants in CYP11B1 influence the susceptibility to coronary heart disease

SNP

Model

Genotype

Diabetes

Hypertension

Case (N, %)

Control (N, %)

OR(95% CI)

p

Case (N, %)

Control (N, %)

OR(95% CI)

p

rs5283

Allele

G

187 (63.61%)

516 (71.67%)

1.00

 

439 (69.24%)

264 (69.47%)

1.00

 
  

A

107 (36.39%)

204(28.33%)

1.45(1.09–1.93)

0.012

195 (30.76%)

116 (30.53%)

1.01(0.77–1.33)

0.939

 

Codominant

GG

55 (37.42%)

185 (51.39%)

1.00

 

150 (47.32%)

90 (47.37%)

1.00

 
  

AA

15 (10.20%)

29 (8.06%)

1.73(0.86–3.46)

0.123

28 (8.83%)

16 (8.42%)

1.06(0.54–2.08)

0.868

  

AG

77 (52.38%)

146 (40.55%)

1.79(1.19–2.70)

0.006

139 (43.85%)

84 (44.21%)

0.98(0.67–1.44)

0.921

 

Dominant

GG

55 (37.42%)

185 (51.39%)

1.00

 

150 (47.32%)

90 (47.37%)

1.00

 
  

AA + AG

92 (62.58%)

175 (48.61%)

1.78(1.20–2.64)

0.004

167 (52.68%)

100 (52.63%)

0.99(0.69–1.4)

0.972

 

Recessive

AG + GG

132 (89.08%)

331 (91.94%)

1.00

 

289 (91.17%)

174 (91.58%)

1.00

 
  

AA

15 (10.20%)

29 (8.06%)

1.29(0.67–2.49)

0.450

28 (8.83%)

16 (8.42%)

1.07(0.56–2.05)

0.842

 

Additive

1.47(1.09–1.98)

0.011

/

/

1.01(0.76–1.34)

0.952

rs4534

Allele

C

186 (63.70%)

406 (56.39%)

1.00

 

356 (56.33%)

236 (62.11%)

1.00

 
  

T

106 (36.30%)

314 (43.61%)

0.74(0.56–0.98)

0.032

276 (43.67%)

144 (37.89%)

1.27(0.98–1.65)

0.071

 

Codominant

CC

57 (39.04%)

108 (30.00%)

1.00

 

98 (31.01%)

67 (35.26%)

1.00

 
 

Homozygote

TT

17 (11.64%)

62 (17.22%)

0.53(0.28–0.99)

0.048

58 (18.35%)

21 (11.05%)

1.97(1.08–3.59)

0.026

 

Heterozygote

TC

72 (49.32%)

190 (52.78%)

0.74(0.48–1.13)

0.157

160 (50.63%)

102 (53.69%)

1.12(0.75–1.68)

0.581

 

Dominant

CC

57 (39.04%)

108 (30.00%)

1.00

 

98 (31.01%)

67 (35.26%)

1.00

 
  

TT + TC

89 (60.96%)

252 (70.00%)

0.69(0.46–1.03)

0.068

218 (68.99%)

123 (64.74%)

1.26(0.86–1.87)

0.238

 

Recessive

TC + CC

129 (88.36%)

298 (82.78%)

1.00

 

258 (81.65%)

169 (88.95%)

1.00

 
  

TT

17 (11.64%)

62 (17.22%)

0.64(0.36–1.14)

0.126

58 (18.35%)

21 (11.05%)

1.84(1.07–3.16)

0.028

 

Additive

0.73(0.54–0.98)

0.036

/

/

1.33(1.01–1.75)

0.044

  1. CHD coronary heart disease; SNP single nucleotide polymorphism; OR odds ratio; 95% CI 95% confidence interval
  2. p values were calculated by logistic regression analysis with adjustment for age and gender
  3. Bold values indicate statistical significance (p < 0.05)